TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT05432401 · UNKNOWN
Trial details
- NCT number
- NCT05432401
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2023-06-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.